Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neuraxis (NRXS) Change in Account Payables (2022 - 2025)

Historic Change in Account Payables for Neuraxis (NRXS) over the last 4 years, with Q3 2025 value amounting to $421881.0.

  • Neuraxis' Change in Account Payables rose 37007.3% to $421881.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$75710.0, marking a year-over-year decrease of 11914.49%. This contributed to the annual value of -$607273.0 for FY2024, which is 5655.52% down from last year.
  • According to the latest figures from Q3 2025, Neuraxis' Change in Account Payables is $421881.0, which was up 37007.3% from -$70499.0 recorded in Q2 2025.
  • Neuraxis' 5-year Change in Account Payables high stood at $748674.0 for Q4 2022, and its period low was -$1.9 million during Q3 2023.
  • Over the past 4 years, Neuraxis' median Change in Account Payables value was $32821.0 (recorded in 2024), while the average stood at $40089.8.
  • In the last 5 years, Neuraxis' Change in Account Payables tumbled by 49134.61% in 2023 and then soared by 37007.3% in 2025.
  • Over the past 4 years, Neuraxis' Change in Account Payables (Quarter) stood at $748674.0 in 2022, then dropped by 14.84% to $637570.0 in 2023, then crashed by 157.27% to -$365161.0 in 2024, then skyrocketed by 215.53% to $421881.0 in 2025.
  • Its Change in Account Payables was $421881.0 in Q3 2025, compared to -$70499.0 in Q2 2025 and -$61931.0 in Q1 2025.